"Cell Line, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cell line derived from cultured tumor cells.
| Descriptor ID |
D045744
|
| MeSH Number(s) |
A11.251.210.190 A11.251.860.180
|
| Concept/Terms |
Cell Line, Tumor- Cell Line, Tumor
- Cell Lines, Tumor
- Line, Tumor Cell
- Lines, Tumor Cell
- Tumor Cell Lines
- Tumor Cell Line
|
Below are MeSH descriptors whose meaning is more general than "Cell Line, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Cell Line, Tumor".
This graph shows the total number of publications written about "Cell Line, Tumor" by people in this website by year, and whether "Cell Line, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 9 | 9 |
| 2004 | 0 | 20 | 20 |
| 2005 | 1 | 22 | 23 |
| 2006 | 0 | 29 | 29 |
| 2007 | 0 | 28 | 28 |
| 2008 | 0 | 39 | 39 |
| 2009 | 0 | 53 | 53 |
| 2010 | 0 | 40 | 40 |
| 2011 | 0 | 52 | 52 |
| 2012 | 0 | 27 | 27 |
| 2013 | 0 | 54 | 54 |
| 2014 | 1 | 34 | 35 |
| 2015 | 0 | 54 | 54 |
| 2016 | 0 | 58 | 58 |
| 2017 | 1 | 46 | 47 |
| 2018 | 0 | 47 | 47 |
| 2019 | 0 | 50 | 50 |
| 2020 | 0 | 40 | 40 |
| 2021 | 0 | 36 | 36 |
| 2022 | 0 | 20 | 20 |
| 2023 | 0 | 9 | 9 |
| 2024 | 0 | 25 | 25 |
| 2025 | 0 | 5 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cell Line, Tumor" by people in Profiles.
-
A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity. Proc Natl Acad Sci U S A. 2025 May 06; 122(18):e2427073122.
-
Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids. SLAS Discov. 2025 Jun; 33:100230.
-
Synergistic Therapeutic Effects of Prussian Blue Erbium-Doped Hydroxyapatite Nanoparticles in Photothermal Photodynamic Cancer Therapy. ACS Biomater Sci Eng. 2025 May 12; 11(5):2639-2652.
-
Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells. Breast Cancer Res. 2025 Mar 07; 27(1):32.
-
PARP12-mediated ADP-ribosylation contributes to breast cancer cell fate by regulating AKT activation and DNA-damage response. Cell Mol Life Sci. 2025 Jan 23; 82(1):58.
-
Targeting Oncogenic RET Kinase by Simultaneously Inhibiting Kinase Activity and Degrading the Protein. J Med Chem. 2025 Jan 09; 68(1):81-94.
-
Real-time viscoelastic deformability cytometry: High-throughput mechanical phenotyping of liquid and solid biopsies. Sci Adv. 2024 Dec 06; 10(49):eabj1133.
-
Oklahoma nitrone-007 is an effective anticancer therapeutic agent targeting inflammatory and immune metabolism pathways in endometrial cancer. J Pharmacol Exp Ther. 2025 Jan; 392(1):100004.
-
MetaPhenotype: A Transferable Meta-Learning Model for Single-Cell Mass Spectrometry-Based Cell Phenotype Prediction Using Limited Number of Cells. Anal Chem. 2024 Dec 10; 96(49):19238-19247.
-
NKX3-2 Induces Ovarian Cancer Cell Migration by HDAC6-Mediated Repositioning of Lysosomes and Inhibition of Autophagy. Cells. 2024 Nov 04; 13(21).